In vivo il-18 supplementation ameliorates lethal acute lung injury in burn-primed endotoxemic mice: A novel anti-inflammatory role of IL-18

Shock

Volumn 32, Issue 5, 2009, Pages 554-562

  Sekine, Kazuhiko ^a   Fujishima, Seitaro ^a   Sasaki, Junichi ^b   Ishizaka, Akitoshi ^c   Aiso, Sadakazu ^d   Aikawa, Naoki ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Division of Pulmonary Medicine   (United States)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BURN; CONTROLLED STUDY; ENDOTOXEMIA; HISTOPATHOLOGY; HYPERSENSITIVITY; IN VIVO STUDY; LUNG INJURY; MACROPHAGE; MOUSE; NONHUMAN;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; BURNS; CELLS, CULTURED; CHEMOKINE CXCL2; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350241805     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31819e2db6     Document Type: Article

References (35)

1. Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75:257-277, 1995.
2. Nerlich M, Flynn J, Demling RH: Effect of thermal injury on endotoxininduced lung injury. Surgery 93:289-296, 1983.
3. Aikawa N, Shinozawa Y, Ishibiki K, Abe O, Yamamoto S, Motegi M, Yoshii H, Sudoh M: Clinical analysis of multiple organ failure in burned patients. Burns Incl Therm Inj 13:103-109, 1987.
4. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, Rotstein OD: Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol 22:412-421, 2000.
5. Yamada H, Miyazaki H, Kikuchi T, Fujimoto J, Kudoh I: Acid instillation enhances the inflammatory response to subsequent lipopolysaccharide challenge in rats. Am J Respir Crit Care Med 162:1366-1371, 2000.
6. Sasaki J, Fujishima S, Iwamura H, Wakitani K, Aiso S, Aikawa N: Prior burn insult induces lethal acute lung injury in endotoxemic mice: effects of cytokine inhibition. Am J Physiol Lung Cell Mol Physiol 284:L270YL278, 2003.
7. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, et al.: A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63:3966-3972, 1995.
8. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:53-72, 2001.
9. Netea MG, Fantuzzi G, Kullberg BJ, Stuyt RJ, Pulido EJ, McIntyre RC Jr, Joosten LA, Van der Meer JW, Dinarello CA: Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol 164:2644-2649, 2000.
10. Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K: Role of interleukin- 18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18Ydeficient mice. Infect Immun 68: 3502-3508, 2000.
11. Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, Saito A: IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 159: 5528-5534, 1997.
12. Kashiwamura S, Ueda H, Okamura H: Roles of interleukin-18 in tissue destruction and compensatory reactions. J Immunother 25(Suppl 1):S4YS11, 2002.
13. Hoshino T, Wiltrout RH, Young HA: IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 162:5070-5077, 1999.
14. Reutershan J, Cagnina RE, Chang D, Linden J, Ley K: Therapeutic antiinflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol 179:1254-1263, 2007.
15. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto M, Heesemann J, Autenrieth IB: IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160:299-307, 1998.
16. Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, Okamura H, Kurimoto M, Dougan G: Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 67:478-483, 1999.
17. Mencacci A, Bacci A, Cenci E, Montagnoli C, Fiorucci S, Casagrande A, Flavell RA, Bistoni F, Romani L: Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1Ydeficient mice. Infect Immun 68:5126-5131, 2000.
18. Stuyt RJ, Netea MG, Verschueren I, Fantuzzi G, Dinarello CA, Van Der Meer JW, Kullberg BJ: Role of interleukin-18 in host defense against disseminated Candida albicans infection. Infect Immun 70:3284-3286, 2002. (Pubitemid 34564195)
19. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M: Interleukin- 18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73:2401-2409, 1999.
20. Ami K, Kinoshita M, Yamauchi A, Nishikage T, Habu Y, Shinomiya N, Iwai T, Hiraide H, Seki S: IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-1.J Immunol 169:4437-4442, 2002.
21. Kinoshita M, Seki S, Ono S, Shinomiya N, Hiraide H: Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burninjured mice. Ann Surg 240:313-320, 2004.
22. Kinoshita M, Shinomiya N, Ono S, Tsujimoto H, Kawabata T, Matsumoto A, Hiraide H, Seki S: Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa. J Immunol 177:4627-4635, 2006.
23. Alexander M, Chaudry IH, Schwacha MG: Relationships between burn size, immunosuppression, and macrophage hyperactivity in a murine model of thermal injury. Cell Immunol 220:63-69, 2002.
24. Coban YK, Aral M: Serum IL-18 is increased at early postburn period in moderately burned patients. Mediators Inflamm 2006:16492, 2006.
25. Finnerty CC, Herndon DN, Chinkes DL, Jeschke MG: Serum cytokine differences in severely burned children with and without sepsis. Shock 27: 4-9, 2007.
26. Finnerty CC, Herndon DN, Jeschke MG: Inhalation injury in severely burned children does not augment the systemic inflammatory response. Crit Care 11:R22, 2007.
27. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG: Cytokine expression profile over time in severely burned pediatric patients. Shock 26:13-19, 2006.
28. Toliver-Kinsky TE, Varma TK, Lin CY, Herndon DN, Sherwood ER: Interferon-gamma production is suppressed in thermally injured mice: decreased production of regulatory cytokines and corresponding receptors. Shock 18:322-330, 2002.
29. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173, 2000.
30. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555, 2002.
31. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M: Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24:1167-1171, 1994
32. Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208, 1993.
33. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155:2222-2229, 1995.
34. Nakatani-Okuda A, Ueda H, Kashiwamura S, Sekiyama A, Kubota A, Fujita Y, Adachi S, Tsuji Y, Tanizawa T, Okamura H: Protection against bleomycininduced lung injury by IL-18 in mice. Am J Physiol Lung Cell Mol Physiol 289:L280-L287, 2005.
35. Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Ikegami H, Kurimoto M: Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin. Anticancer Res 18:4267-4274, 1998.